Filing Details

Accession Number:
0001209191-23-014434
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-02 06:24:47
Reporting Period:
2023-02-28
Accepted Time:
2023-03-02 06:24:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON Biological Products, (No Disgnostic Substances) (2836) 342037594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631338 Charles Theuer C/O Tracon Pharmaceuticals, Inc.
4350 La Jolla Village Drive, Suite 800
San Diego CA 92122
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-28 200 $1.52 340,118 No 4 P Direct
Common Stock Acquisiton 2023-03-01 4,800 $1.52 344,918 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct